2024.12.18
*Report* “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” was held as an open-house event.
On Tuesday, December 17, 2024, “Public Project ‘The Frontiers of Regenerative and Cellular Medicine that will Change Future Medicine’ was held at COCOLAND.
On the day of the event, we received greetings from the President of Yamaguchi University, the Governor of Yamaguchi Prefecture, and the Mayor of Ube City.
The mayor of Ube City said that Ube City has the potential to target a global market worth tens of trillions of yen in a city of more than 100,000 people.
Afterwards, each of the eight speakers spoke about “initiatives that only Ube City can undertake, because Ube is Ube,” including research projects and human resource development conducted in collaboration with industry, academia, and public finance.
Through such activities, the Institute will continue to make further strides toward achieving its mission.
Date: Tuesday, December 17, 2024, 13:00-16:35
Place: COCOLAND
Participants: 175 (85 on-site participants and 90 online participants)
Lecture Contents
Title 1 “Possibility of New Therapeutic Methods through Collaboration of Cells and Rehabilitation” (Prof. Hideyuki Ishihara, Yamaguchi University)
(Professor Hideyuki Ishihara, Yamaguchi University, Director Rui Yuge, Space Bio Laboratories, Inc.)
Title 2 “Development of ‘cryopreserved’ fibroblast cell sheets from Yamaguchi Prefecture through industry-academia-government collaboration: A story of cell sheets applied to non-healing wounds
(Hiroshi Ishikawa, Deputy Director, Yamaguchi Prefecture Department of Industry and Labor; Satoru Miyazawa, Director, Central Glass Co.)
Subject 3 “Fostering specialists in cell production
(Professor Taro Takami, Yamaguchi University)
Subject 4 “To create regenerative and cellular therapies from Yamaguchi University to support global health” (Prof. Koji Tamada, Yamaguchi University)
(Professor Koji Tamada, Yamaguchi University)
Subject 5 “Efforts of Ministry of Economy, Trade and Industry in the field of regenerative/cell medicine and gene therapy” (Professor Koji Tamada, Yamaguchi University)
(Hirokazu Shimoda, Director, Biological and Chemical Industry Division, Commerce and Service Group, METI)
